Statement of Commissioner Rebecca Kelly Slaughter Regarding the Collaboration Act Report
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P234800
The FTC’s five Commissioners issue statements on a range of important topics to engage with the public and express the views of the Commission as well as their own individual views.
Displaying 181 - 200 of 1024
Joint Comment of the United States Department of Justice and Federal Trade Commission Regarding Exemptions to Permit Circumvention of Access Controls on Copyrighted Works
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Statement Of Commissioner Rebecca Kelly Slaughter joined By Chair Lina M. Khan And Commissioner Alvaro M. Beodya Regarding FTC Staff Report: “Market Factors Relevant to Infant Formula Supply Disruptions”
Date
By
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya in the Matter of Avast Limited
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Statement of Chair Khan, Joined by Commissioners Slaughter and Bedoya, Regarding the Final Trade Regulation Rule on Impersonation of Government and Businesses
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
R207000
Joint Statement of Chair Lina M. Khan, Commissioner Rebecca Kelly Slaughter, and Commissioner Alvaro M. Bedoya In the Matter of Blackbaud, Inc.
Date
By
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
2023181
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the FY2022 HSR Annual Report to Congress
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
P110014
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter In the Matter of Sanofi/Maze Therapeutics
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
D09422
File
Text of Statement
(126.92 KB)
Statement of Commissioner Alvaro M. Bedoya On FTC v. Rite Aid Corporation
Date
By
Alvaro Bedoya, Former Commissioner
Matter Number
2023190
Statement of Chair Lina M. Khan Joined By Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya In the Matter of Amgen, Inc. and Horizon Therapeutics plc
Date
By
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya, in the Matter of EQT Corporation
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
2210212
Statement of Chair Lina M. Khan Regarding the Policy Statement Concerning Reliance on Prior PBM-Related Advocacy Statements and Reports
Date
By
Lina M. Khan, Former Chair and Commissioner
Statement Of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P234000
Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding FTC-DOJ Proposed Merger Guidelines
Date
By
Lina M. Khan, Former Chair and Commissioner
Matter Number
P234000
Statement of Chair Lina M. Khan in the Matter of Smoke Away
Date
By
Lina M. Khan, Former Chair and Commissioner
File
Displaying 181 - 200 of 1024